Standort in Gefahr: Absagen für den Investitionsgipfel: Unternehmenschefs kritisieren deutsche Industriepolitik
Die Bundesregierung wirbt mit dem „Invest in Germany“-Gipfel um Vertrauen und Geld internationaler Unternehmen. Doch viele äußern sich kritisch – Pharmachefs sagen sogar ihre Teilnahme ab.
As the crucial investment summit organized by the German government approaches in Berlin, the mood in certain industries is gloomy. Several key energy laws have been pending for months, causing unease among businesses. The healthcare sector is also experiencing frustration due to austerity measures. Chancellor Friedrich Merz and his cabinet aim to convey that investments are welcome and that Germany is an attractive location for them.
To this end, they have invited domestic and international company executives to the "Invest in Germany" summit on Monday and Tuesday. Many CEOs will have the opportunity to hold private meetings with the chancellor and ministers. The timing is generally favorable. Yves Meyer-Bülow, a partner at infrastructure investor I Squared, states, "Germany has the historic opportunity to make its infrastructure a competitive advantage again.
After two decades of insufficient public investment, the catch-up need is significant." Roman Waleczek, managing director of financial services firm Rothschild, adds, "Germany's industrial location offers great investment opportunities at the moment, particularly in scaling and modernizing the economy. The 'Invest in Germany Summit' sends an important signal."
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
